skip to Main Content

Gilead Sciences announces collaboration with Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy to address inequities in HIV care

FOSTER CITY, Calif. –News Direct– Gilead Sciences

FOSTER CITY, Calif., ATLANTA and NEW ORLEANS, Aug. 18, 2022 /3BL Media/ — Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new health equity collaboration with the Satcher Health Leadership Institute ( SHLI) at Morehouse School of Medicine and the Center for Minority Health and Health Disparities Research and Education (CMHDRE) at Xavier University of Louisiana’s College of Pharmacy. The collaboration focuses on addressing inequities in HIV care for black communities in the southern United States. Gilead has a broad and longstanding commitment to advancing global health equity, which it views as essential to help end the HIV epidemic and improve health outcomes for all. The company’s health equity strategy focuses on working with organizations that reach underrepresented and disproportionately affected communities.

Research shows that inequity leads to higher rates of HIV infection, as well as poorer HIV clinical outcomes among Black Americans. The COVID-19 pandemic has further highlighted and exacerbated these health inequalities, particularly in the southern United States. SHLI and CMHDRE are at the forefront of efforts to improve access to HIV care for Black communities in the southern region of the United States. Gilead will provide total funding of $4.5 million over three years to support its work in three cities: Atlanta, Baton Rouge, Louisiana and New Orleans.

The partnership between SHLI and CMHDRE, with support from Gilead, aims to address critical gaps in care by:

  • Increase understanding of the impact of COVID-19 on the health care delivery system in the Black community

  • Realign HIV services to reflect the impact of the COVID-19 pandemic

  • Provide training in culturally appropriate HIV care, including stigma reduction strategies

  • Increase access to and use of culturally appropriate care for Black people affected by the HIV epidemic

“Gilead knows that scientific innovation has the greatest impact on patients when we help break down societal barriers to care, such as discrimination and stigma. We are committed to investing in organizations, community leaders and experts working to address the underlying determinants of health outcomes,” said Rashad Burgess, Vice President of Advancing Black Health and Equity , Gilead Sciences. “This collaboration will focus on the most prevalent barriers in Black communities and help increase access to HIV care to produce better outcomes for Black people.”

“While the COVID-19 pandemic has been a setback for the U.S. health care system as a whole, we need to bring to the fore the disproportionately affected communities who were already historically marginalized before the pandemic, including people living with HIV,” said Daniel E. Dawes, JD, executive director of the Satcher Health Leadership Institute at Morehouse School of Medicine and author of The Political Determinants of Health. “The Satcher Health Leadership Institute will work with Gilead and Xavier University of Louisiana to ensure these communities are not an afterthought.”

“The Xavier Center for Minority Health and Health Disparities Research and Education at the College of Pharmacy is proud to partner with Gilead and the Satcher Health Leadership Institute at Morehouse School of Medicine on such an important initiative. said Dr. Kathleen Kennedy, Dean of Xavier. University of Louisiana College of Pharmacy. “Xavier is a top producer of African Americans with a Doctor of Pharmacy, and we instill in our graduates Xavier’s mission and desire to serve the underserved in an effort to alleviate health disparities. for underrepresented communities.”

This latest collaboration is part of Gilead’s broader health equity strategy to support community organizations around the world in addressing the social determinants of health. A recent report commissioned by Gilead, “HIV In The Time of COVID-19: Leaving No-One Behind to Truly End the HIV Epidemic,” details a wide range of barriers to health equity, including social factors and economic. While predictors of health outcomes such as race, ethnicity and gender have long existed, the COVID-19 pandemic has exacerbated health inequities, particularly for marginalized communities and those affected by poverty. HIV. Gilead is increasing its investments to address these underlying inequalities highlighted by the intersection of the two health crises.

Other Gilead programs that address health equity include COMPASS Initiative®, a ten-year, $100 million commitment to address HIV/AIDS inequities in the southern United States, which continues to challenge the structural barriers most prevalent in black communities. Gilead’s Zeroing In™ program supports communities in 41 countries that have been doubly impacted by HIV and the COVID-19 pandemic. Gilead also created a $10 million Racial Equity Community Impact Fund to support organizations that address racial inequalities that affect Black communities. In its most recent report, AIDS Donors named Gilead the top global philanthropic funder of HIV/AIDS programs.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has been pursuing and achieving breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, cancer and inflammation. Gilead operates in more than 35 countries around the world, with headquarters in Foster City, California.

Gilead has promoted equity, particularly equity in health care, since the company brought its first therapies to market. Through global partnerships, Gilead medicines today reach millions of people in low- and middle-income countries around the world. In the United States, Gilead has committed more than $100 million over 10 years through the COMPASS Initiative® to community organizations fighting HIV in the southern United States. In 2020, Gilead launched the Racial Equity Community Impact Fund to support organizations that address racial inequality affecting Black communities across the United States.

About the Satcher Health Leadership Institute at Morehouse School of Medicine

The Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine aims to be the leading transformative force for health equity in policy, leadership development, and research. Rooted in the legacy of its founder, the 16th Surgeon General of the United States, Dr. David Satcher, SHLI’s mission is to create systemic change at the intersection of politics and equity by focusing on three priority areas: political determinants of health, health system transformation, and mental and behavioral health. In collaboration with key strategic partners, SHLI enhances leadership among diverse learners, conducts cutting-edge research on the drivers of health inequities, and advances evidence-based policy, all with the goal of contributing to the achievement health equity for all population groups. Learn more at;

About Xavier University of Louisiana and the Center for Minority Health and Health Disparities Research and Education

Founded in 1925, Xavier University of Louisiana is the only historically black and Catholic university in the country. Located in New Orleans, Louisiana, its liberal arts-based programs in diverse fields provide students with an unbeatable combination of traditional classroom study, hands-on research, service-learning opportunities, and hands-on experiences. of life. Xavier is recognized by the United Negro College Fund (UNCF) as the top performing HBCU in terms of upward graduate mobility (2022) and is a nationally recognized leader in STEM and health sciences. Xavier is known for producing more African-American students graduating from medical school each year than any other university in the country, and its College of Pharmacy is one of the top producers of African-American pharmacists. Visit to learn more.

The Center for Minority Health and Health Disparities Research and Education (CMHDRE) at Xavier’s College of Pharmacy was founded in 2004 to improve health outcomes for racial and ethnic minorities. CMHDRE’s mission is to provide the infrastructure necessary to conduct research and provide community education and clinical services to eliminate health disparities using community engagement and collaborative partnerships. It conducts basic and translational research, provides culturally relevant education and clinical services in the community, and educates current and future healthcare providers as a leader in the initiative to improve population health outcomes. minorities in the region.

Gilead and the Gilead logo are trademarks of Gilead Sciences, Inc. or its affiliates.

For more information about Gilead, please visit the company’s website at, follow Gilead on Twitter (@Gilead Sciences), or call Gilead Public Affairs at 1-800-GILEAD-5 or 1 -650-574-3000.

See the source version on

Hayley Home, Gilead (916) 402-2864

Jareese K. Stroud, SHLI(404) 752-1907

Regi Reyes, Xavier University of Louisiana (504) 520-5240

Source: Gilead Sciences, Inc.

View original content here.

Explore additional media content and other ESG stories from Gilead Sciences at

See source version at – pharmacy-to-address-injustices-in-hiv-care-182926461

Back To Top